2008

17 November 2008
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery

14 November 2008
Hodogaya promotes its transport materials for the Novaled PIN OLED™ structures

11 November 2008
IMM, Cenix and Alnylam discover new targets in Malaria Infection with RNAi Technology

20 August 2008
Novaled achieves break through in organic CMOS-type technology

24 July 2008
Santhera erhält erste Marktzulassung: Catena® erhält Zulassung von Health Canada zur Behandlung von Friedreich-Ataxie

28 May 2008
CDT, Sumitomo Chemical and Novaled will collaborate to evaluate Novaled PIN OLED™ structures in Polymer OLEC devices.

20 March 2008
Cenix BioScience and CellCentric sign Framework Research Agreement for RNAi-Based Target Validation

19 March 2008
Cenix BioScience signs Framework Research Agreement with AstraZeneca for RNAi-Based Drug Discovery

10 January 2008
Saint-Gobain and Novaled have demonstrated the feasibility of large area OLEDs